Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events

To assess the efficacy and safety of ezetimibe versus placebo or ezetimibe plus other lipid-modifying drugs versus other lipid-modifying drugs alone for the prevention of CVD events and all-cause mortality events.

This is a protocol.

Share/Save